Luke Stoeckel, PhD is the Director for Clinical Neuroscience at the MGH-Harvard Center for Addiction Medicine. He is a licensed clinical neuropsychologist. He completed his undergraduate studies at Harvard College, his graduate studies in the Medical/Clinical Psychology program at the University of Alabama at Birmingham, and internship/postdoctoral training at MGH and Harvard Medical School (HMS). His research focuses on the investigation of abnormal brain-behavior relationships in disorders such as addiction, obesity, and schizophrenia. He has received several prestigious awards including the Norman E. Zinberg addiction research fellowship from the HMS Department of Psychiatry, a Brain & Behavior Research Foundation (NARSAD) Young Investigator Award, and an NIMH NCDEU New Investigator Award. His research aims to improve our understanding of the pathophysiology of addiction in order to develop new, more effective individualized therapies and is supported by the National Institute on Drug Abuse and the Brain & Behavior Research Foundation. Finally, he serves as a resident advisor for first-year students at Harvard College.